METHODS FOR IMPROVEMENT OF MEMORY AND COGNITIVE FUNCTION AND TREATMENT OF MEMORY DISORDERS AND COGNITIVE DISORDERS Russian patent published in 2022 - IPC C07D401/06 C07D413/14 A61K31/4184 A61K31/44 A61P25/28 

Abstract RU 2785125 C2

FIELD: pharmacology; medicine.

SUBSTANCE: invention relates to the field of pharmacology and medicine, namely to the treatment of cognitive functions in a subject. A method for the treatment for improvement of memory and/or cognitive function in a subject who needs such treatment is disclosed, including administration to the subject who needs such treatment of therapeutically effective amount of an antagonist of calcium channels of T type. In this case, the antagonist of calcium channels of T type is MK-8998 or its pharmaceutically acceptable salt. The treatment is used for a condition selected from a group consisting of agnosia, amnesia, Angelman syndrome, Asperger syndrome, autism, cerebral amyloid angiopathy, cognitive disorder caused by alcohol or medications, degenerative dementia, dementia associated with intracranial tumors, Levi’s body disease, multi-infarction dementia, Dravet syndrome, Prader-Willi syndrome, trisomy (including trisomy 21 (Down syndrome)), and Wernicke-Korsakov syndrome.

EFFECT: invention provides effective treatment of memory and/or cognitive function by administration of an antagonist of calcium channels of T type.

MK-8998

7 cl, 1 dwg, 1 tbl, 2 ex

Similar patents RU2785125C2

Title Year Author Number
METHODS OF TREATING DRAVET SYNDROME 2018
  • Maricich, Yuri
  • Newbold, Evan
RU2767661C2
COMPOSITIONS AND METHODS FOR TREATING COGNITIVE DISORDERS 2005
  • Bonkhaus Duglas Vill'Jam
  • Martin Rene Sharon
RU2420318C2
DPP-IV INHIBITORS FOR TREATMENT OF NEURODEGENERATION AND COGNITIVE DISORDERS 2005
  • Kh'Juz Tomas Ehduard
RU2394570C2
COMPOSITIONS, CONTAINING CHOLINESTERASE INHIBITOR FOR TREATING COGNITIVE DISORDERS 2010
  • Staubli Ursula V.
  • Donello Dzhon E.
RU2607946C2
PHARMACEUTICAL COMPOSITION FOR PREVENTING AND TREATING MENTAL, BEHAVIOUR AND COGNITIVE DISORDERS 2012
  • Morozova Margarita Alekseevna
  • Beniashvili Allan Gerovich
  • Zapol'Skij Maksim Ehduardovich
RU2488388C1
METHYLTHIONINIUM AS COGNITIVE ENHANCER 2020
  • Riedel, Gernot
  • Klein, Jochen
  • Schwab, Karima
  • Wischik, Claude Michel
  • Harrington, Charles Robert
RU2824584C2
3β-(Benzyloxy)-17α-METHYL-PREGN-5-EN-20-ONE FOR USE IN THE TREATMENT OF COGNITIVE DISORDERS 2019
  • Piazza, Pier-Vincenzo
  • Fabre, Sandy
  • Monlezun, Stephanie
  • Metna, Mathilde
  • Vallee, Monique
  • Revest, Jean-Michel
  • Cota, Daniela
  • Marsicano, Giovanni
  • Marighetto, Aline
  • Ozaita, Andres
  • Maldonado, Rafael
RU2796005C2
THERAPEUTIC APPLICATION OF SELECTIVE INHIBITORS PDE10 2003
  • Lebel Lorrejn Ehnn
  • Menniti Frank Sehm'Juehl'
  • Shmidt Kristofer Dzhozef
RU2303259C2
CYCLOPENTYL DERIVATIVES 2004
  • Melloni P'Ero
  • Sabido David Chibehle Marija
  • Rehstivo Alessandra
  • Forlani Roberto
  • Sal'Vati Patrisija
RU2372325C2
5-HT RECEPTOR AGONIST COMPOUNDS FOR TREATING COGNITIVE DISORDERS 2010
  • Bitti Dehvid
  • Shehn' Fehj
  • Smit Zhaklin A. M.
  • Makkinnell Robert Mjurrej
  • Chan Rehj
RU2569056C2

RU 2 785 125 C2

Authors

Maricich, Yuri

Dates

2022-12-05Published

2018-04-26Filed